Ferulic Acid Purity Is Not Enough for a Stable Cosmetic Formula
Disclosure: We may earn a commission if you purchase through links on this page, at no additional cost to you.
Quick Answer
A ferulic acid listing can show 98% or 99% purity and still leave the most important formulation questions unanswered. Is the material predominantly trans-ferulic acid? What does the assay measure? Can the powder be dissolved in the intended solvent system without crystallising after dilution? How will light, oxygen, heat and packaging affect the finished antioxidant serum? Those are separate qualification questions, not details that can be inferred from the headline percentage.[1,3]
For an initial purchase screen, confirm ferulic acid identity and CAS 1135-24-6, the assay basis and method, trans/cis or isomer information where relevant, moisture or loss on drying, residual solvents, heavy metals and microbiological limits. Then match the grade to the delivery route. Free ferulic acid is not a plug-and-play water-phase powder: solubility, pH, solvent composition and cooling history can determine whether the final formula is clear, hazy or crystalline.
A useful COA should therefore be read alongside the TDS and the intended formula process. If the supplier only provides 98% ferulic acid and a generic solubility statement, the material may be suitable for a sample conversation, but it has not yet answered a production qualification question.
Why the Percentage Does Not Settle the Purchase
The number on a marketplace page may represent an assay specification, a batch result, an HPLC area percentage, a dry-basis value or a generic purity claim. These fields are not interchangeable. A 99% area result can be technically useful, but it does not automatically tell the buyer the trans/cis ratio, the water content, the residual-solvent profile or how the powder behaves in a glycol-water system.
Ferulic acid also appears in several commercial contexts: free ferulic acid, rice-bran-derived material, synthetic material, ethyl ferulate and other derivatives. These are not the same raw material. A derivative may be selected for a different oil-phase or stability route, but it should not be compared with free ferulic acid as though only the supplier had changed.
Scientific reviews describe ferulic acid as a phenolic compound with moderate water solubility and sensitivity to degradation conditions. The trans form is generally the dominant and more stable isomer, while light can drive isomerisation. The practical message for a buyer is not that every batch will fail under light; it is that isomer identity, method and packaging deserve a place in the specification when the formula depends on antioxidant performance.[3,4]
The Real Formulation Decision Is the Solvent and Stability System
| Route | What it can solve | What must be verified | Failure signal |
|---|---|---|---|
| Glycol or alcohol led | Provides a route for a clear or translucent serum | Solubility at working concentration, water tolerance, pH, cooling and crystallisation | Clear while warm, crystals after dilution or storage |
| Part aqueous system | Balances handling, sensory feel and solvent load | Order of addition, final pH, solvent percentage, filtration and appearance | Haze, sediment or delayed loss of clarity |
| Encapsulated or complexed system | Can improve apparent solubility or protect the active | Carrier identity, loading, release method, finished-system stability | Raw assay passes but delivery data are missing |
| Oil or derivative route | Moves the project away from free-acid water solubility limits | Exact chemical identity, oil compatibility, label and regulatory treatment | A derivative is sold under an imprecise parent-ingredient title |
A supplier's water soluble label should be treated as a test claim, not a universal property. Ask for the tested concentration, temperature, pH, water quality, solvent composition, and whether the result was a clear solution or a dispersion. If those conditions are absent, the statement is not portable to the finished formula.
What Trans and Cis Mean for a Buyer
Isomer information matters because the material name alone does not communicate the ratio. A buyer does not need to assume that every cis signal is unacceptable; the correct question is whether the supplier controls the identity and whether the result is consistent with the intended grade. Ask which chromatographic method separates the isomers, whether the COA reports a trans result or only total ferulic acid, and whether light exposure was controlled during sampling and storage.
This is also where a natural-source claim can become misleading. Rice bran origin may describe the source of the extract, but it does not by itself define the final ferulic-acid assay, isomer profile, carrier residue or purification level. Natural and 99% answer different questions. Keep source, identity and assay as separate fields in the comparison sheet.[5]
COA Fields That Should Change the Shortlist
- Identity. Ferulic acid, CAS 1135-24-6, product code, appearance, and whether the material is free acid or a derivative.
- Assay. Result, limit, method, basis, and whether the result is total ferulic acid or an isomer-specific measurement.
- Isomer profile. A trans/cis method, or a clear statement that the supplier does not control this field.
- Physical controls. Moisture or LOD, particle description, colour, melting range, and any insoluble-matter limit relevant to the process.
- Contaminants. Residual solvents, heavy metals, pesticide or microbiological controls where the source and destination require them.
- Traceability. Lot number, COA issue date, manufacturer or issuer identity, storage conditions, and retest or expiry basis.
Do not silently convert a typical value into a release specification. If the TDS says trans form preferred but the COA has no isomer result, record the gap as not independently verified. If the supplier provides a solubility number without the solvent system, record the number as incomplete rather than using it to promise a clear serum.
Why Colour and Crystallisation Need Separate Investigations
Formulators and consumers often notice colour first. Discussions around vitamin C and ferulic acid products repeatedly ask whether a yellowing serum is oxidised, whether refrigeration changes its appearance, and whether a clear product is still within specification. Those are legitimate questions, but colour is not a standalone assay. A pale yellow powder or serum can arise from the raw material, concentration, pH, other antioxidants, packaging or degradation. The buyer needs a defined colour method and a stability protocol.
Crystallisation is a different failure mode. A formula may be clear at the processing temperature and become hazy after cooling, dilution or water loss. The right pilot is not simply whether the powder dissolves in hot water. It is a controlled test at the intended concentration, solvent ratio and pH, followed by observation after cooling and storage. Record the time to clarity, visible particles, absorbance or appearance method, and assay if the formula is commercially important.
The frequently cited 2005 study concerns a defined topical solution containing 15% L-ascorbic acid and 1% alpha-tocopherol. It supports the role of ferulic acid in that tested antioxidant system; it does not qualify an arbitrary supplier powder or prove that every vitamin C serum will remain stable. Keep the formula evidence tied to the tested composition.[1]
A Buyer-Side Pilot That Is Worth the Time
- Request a sample and the matching lot COA, and record the lot number on the sample container before opening it.
- Prepare the intended solvent system at the target ferulic-acid concentration. Run a second, deliberately lower concentration to identify the crystallisation margin.
- Record pH, temperature, order of addition, mixing time, light exposure, container type and headspace.
- Inspect immediately after preparation, after cooling, after dilution and after a defined storage interval. Do not use looks clear as the only endpoint.
- If the active is combined with vitamin C or vitamin E, test the complete system. Evidence from a published formula cannot be transferred without checking the actual composition.
- Compare the pilot result with the commercial lot current COA before approving repeat supply.
Two Current Sourcing Leads
The two leads below are dated marketplace observations, not supplier rankings, and they are deliberately different: one is a free-acid powder offer, the other is a derivative included to prevent accidental substitution. Both were confirmed to land on the Product IDs shown. Exact assay method, isomer control and solvent data are not stated in the public results and still require current lot documents.
A product listing and a supplier storefront are different routes and are not interchangeable.
RFQ Questions Worth Sending
- Is the material free ferulic acid or a derivative? Please confirm INCI, CAS 1135-24-6 where applicable, and the exact product code.
- Does the assay measure total ferulic acid, trans-ferulic acid or an HPLC area percentage? Please provide the method and basis.
- Do you control or report trans/cis composition? If yes, which method and acceptance range are used?
- Please provide a recent lot-specific COA, TDS and SDS, including moisture or LOD, residual solvents, heavy metals and microbiological limits where applicable.
- What solvent system and concentration were used for the supplier's solubility statement? Was the result a clear solution or a dispersion?
- What packaging, storage temperature, light protection and retest or expiry basis apply to the proposed lot?
- If the product is rice-bran-derived, what carrier, extraction residue or standardisation step remains in the final material?
When the Candidate Should Be Paused
Pause the listing when it combines ferulic acid, ethyl ferulate and a generic ferulic derivative under one product title. Pause it when the page says 99% but the COA cannot explain the assay basis, or when the clear-solution claim has no solvent, temperature or concentration. A low price is not the issue; an undefined identity or an untestable stability claim is.
A candidate can remain in the exploratory pool when one non-critical field is missing and the supplier is willing to provide a sample and a method note. It should not be treated as production-qualified until the identity, lot traceability and process-relevant evidence are closed. That distinction lets procurement continue without turning a marketplace description into a technical approval.
Bottom Line
Ferulic acid is a useful cosmetic antioxidant, but the buyer decision is not 98% or 99%. It is whether the exact material identity, isomer information, solvent route, packaging and stability test fit the formula being manufactured. Free ferulic acid, ethyl ferulate and rice-bran extracts may all appear in the same search results while presenting different technical and commercial questions.
Use purity as the opening filter, not the conclusion. Request the method-specific documents, test dissolution and crystallisation under the actual process, and keep published vitamin C and vitamin E evidence tied to the formula that was actually studied. For procurement, the most useful comparison is a matched technical packet: same identity, same assay basis, same storage assumptions and the same formulation test. This produces a defensible supplier decision even when public listings use different language.
References
- Lin FH, et al. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. Journal of Investigative Dermatology. 2005. https://pubmed.ncbi.nlm.nih.gov/16185284/
- Das S, et al. Stabilization of ferulic acid in topical gel formulation via encapsulation. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7378829/
- Jacobo-Velazquez DA, et al. Ferulic Acid: Mechanistic Insights and Multifaceted Applications. Molecules. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12472962/
- Roux J, et al. Ferulic Acid Use for Skin Applications: A Systematic Review. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12175833/
- Truong HT, et al. A Method for Ferulic Acid Production from Rice Bran Oil. Applied Sciences. 2017. https://www.mdpi.com/2076-3417/7/8/796
Related content
Continue exploring related ingredient research and sourcing guides.
Creatine Monohydrate 200 Mesh vs Micronized: What Buyers Should Verify
A 200-mesh claim and the word micronized are both shorthand. What each one can and cannot tell you, when sieve analysis is enough, and how to write a particle-size limit that a lot has to meet.
80 Mesh vs 200 Mesh Creatine Monohydrate: How Buyers Should Specify Particle Size
Mesh is a sieve shorthand, not a specification. How to make 80 and 200 mesh comparable, test dispersion at the intended dose, and write a particle-size limit into the RFQ.
L-Carnitine L-Tartrate COA: How to Read a 99% Assay and a 68% L-Carnitine Result
A salt assay near 99% and an L-carnitine result near 68% can describe the same pure material. How to name the analyte, the basis and the method so a COA actually releases a lot.
L-Theanine COA Checklist for Ingredient Buyers
A 98% HPLC result is only the headline. How to tie the L-theanine COA to a lot, read the assay basis, and keep L-form evidence separate from a routine non-chiral assay.